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Abstract
Objective: To estimate 12-month prevalence and co-occurrence of symptoms of specific mental
problems among US adolescents (12–17 years) by age, sex and racial/ethnic subgroups.
Method: Data from the 2000 National Household Survey of Drug Abuse (NHSDA) adolescent
sample are used to estimate prevalence and co-occurrence rates using the DISC predictive scales.
Multiple logistic regressions were used to derive significant correlates of each domain of DPS-
derived symptom cluster indicators of psychiatric problems and of severe comorbidity, with
control of demographics and environmental factors.
Setting: The National Household Survey on Drug Abuse (NHSDA), a national household
probability sample, includes a nationally representative sample of 12–17 year-old adolescents (N =
19,430), through in-home surveys.
Results: Three out of five adolescents screened positive for at least one DPS symptom cluster with
estimates for specific symptom cluster ranging over 9.7% (substance use disorder), 13.4%
(affective), 36.3% (disruptive-behavior), and 40.1% (anxiety). Co-occurrence was high with almost
one-third of any DPS symptom cluster reporting multiple positive screens of four or more clusters.
Blacks and younger females were most likely to report mental health problems and co-occurrence.
Conclusion: Mental health problems among U.S. youth may be far more common than previously
believed, although these symptoms have not yet reached the point of clinical impairment. The data
speak to important patterns of age, gender and racial/ethnic differences in mental health problems
deserving of further study.
Introduction
Although mental health has become increasingly impor-
tant in our healthcare model and definition of health,
especially during childhood and adolescence[1,2], little is
known about actual prevalence of various psychiatric dis-
orders among adolescents in the general population. Cur-
rent estimates range from 10% to 60% [3-5], based mostly
on local community or treatment samples and dependent
upon the case-finding protocol used. Evidence from adult
samples suggests that many disorders with psychiatric
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although estimates of the earlier onset of adult disorders
may be unreliable due to errors in retrospective recall[8].
It is well documented that childhood and adolescent
mental health problems have profound implications for
negative adult sequelae [9-13]. By official estimate, at any
one time, about 20% of US children and adolescents have
at least one diagnosable mental health disorder[1]. How-
ever, in their longitudinal study of 9–16 year-old adoles-
cents, Costello et al. reported 36.7% having at least one
psychiatric disorder (by DSM-IV criteria) during the study
period (although the prevalence of a number of disorders
dropped precipitously by age 12)[4]. Turner & Gil
reported that 60% of their community youth sample (age
19–21) met lifetime criteria for one or more mental disor-
ders, including substance use disorders (SUD), with full
DSM-IV diagnosis[5].
Recent national surveys provided some important epide-
miological information about the prevalence of psychiat-
ric disorders among adults [14-18], but our
understanding of the scope of psychiatric disorders or
symptoms among children and adolescents is limited by
a number of methodological constraints, including small
samples, or samples from clinics or institutions; overly
specific research foci; and screening questions either lim-
ited in number or not closely aligned with DSM diagnos-
tic criteria. Thus, the estimates of prevalence in the general
U.S. adolescent population cannot be reliably made, pre-
senting a major obstacle for estimating the course and
magnitude of adolescents' mental health problems, the
degree of both need and unmet need, and for developing
effective prevention and intervention programs for this
critical age group[4,19] Estimates from adult national
probability samples suggest that nearly half of all adult
cases report onset by age 14, and three-quarters by age
24[6,18]. However, it is not clear what major types of
mental health problems adolescents are confronted with,
and to what extent. Moreover, there is a lack of ethnic
group-specific estimates of mental health needs that
would be required for more targeted services for various
subpopulations. Importantly, members of racial/ethnic
minority groups report some of the highest rates of unmet
need for treatment as adults[20,21].
One way to provide uniform estimates of mental prob-
lems would be to include in national surveys of the gen-
eral population structured diagnostic interviews or
selected screening items or scales of symptoms of psychi-
atric problems that have high predictive value for diagno-
sis. Although such a survey cannot constitute an actual
diagnosis of disorder, it can facilitate identification of
groups at high risk, as well as help elucidate differential
patterns in important demographic groups, including age,
gender and race/ethnicity. An important caveat of using
this approach to estimate psychiatric symptoms among
adolescents is that this is a group experiencing profound
developmental changes across biological, psychological
and social domains[2]. Thus, there remains some ques-
tion of the extent to which psychiatric symptoms are sta-
ble indicators of some underlying need or indicative of a
developing disorder[22], or whether they are indicative of
normal (vs. problematic) behavior[23]. Moreover, cross-
sectional surveys can only present a snapshot of preva-
lence estimates; changes over time and the ways in which
such symptoms evolve into diagnosable disorders cannot
be measured. Several empirical studies based on the Great
Smokey Mountains Study[24] have demonstrated pat-
terns of age effects on disorders and disabilities that sug-
gest psychiatric problems drop substantially by age 12,
increase between ages 12 to 15, and drop again at age
16[4,22]. Nonetheless, it remains an important task to
derive accurate estimates of prevalence of mental health
problems in this age group in the national adolescent
population.
Several large-scale national surveys of U.S. adults have
included structured diagnostic interviews, for example,
the Epidemiological Catchment Area Study (ECA)[25] the
National Comorbidity Survey and the National Comor-
bidity Survey-Replication (NCS, NCS-R, age 15–
55)[14,15,18]. Although the parallel National Comorbid-
ity Survey – Adolescents (NCS-A,[18]) is a much-needed
addition to the field, it has yet to yield estimates of psychi-
atric disorder among adolescents in the US. In the NCS,
Kessler[14] reported that 12-month prevalence of mental
disorders was consistently the highest in their youngest
cohort, the 15–24 age-group. Gender differences were
also reported in the NCS by Kessler[18,26].
One study that has recently incorporated screening items
for mental health problems among adolescents in the
United States is the NIMH Methods for the Epidemiology
of Childhood and Adolescent Mental Disorders Study
(MECA)[27]. This study used probability household sam-
ples of children aged 9 to 17 and their adult caretakers
from four sites. The final sample included 1285 pairs of
child respondent and adult caretaker. The screening
instrument used in this study was a recently-developed
instrument for diagnostic screening of children and ado-
lescents, the Diagnostic Interview Schedule for Children
(DISC-2.3)[28]. The DISC-2.3 is a highly structured diag-
nostic instrument, which screens for six categories of the
most common mental disorders among children and ado-
lescents (DSM-III-R)[29]: anxiety, affective, disruptive
behavior, mood, substance use, miscellaneous (e.g., eat-
ing disorders), and psychotic disorders. This instrument
has demonstrated good criterion validity with independ-
ent clinical diagnoses[30] and is a reliable tool for the
screening of childhood mental disorders[28]. Almost onePage 2 of 12
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tic criteria for any disorder[28]. However, the MECA sam-
ples were small and local, and were not representative of
the US population as a whole.
Another study that is in the process of developing esti-
mates of child and adolescent (ages 4 – 17) mental health
problems in the U.S., is the National Health Interview Sur-
vey (NHIS), an annual household survey with a nation-
ally representative sample. In the 2001 and 2003
Supplements to the NHIS, the parent report version of the
Strengths and Difficulties Questionnaire (SDQ) was
included, and in the 2002 NHIS, a subset of items from
this measure was included. Parent reports for approxi-
mately 9000 to 10000 children aged 4 – 17 were collected
on five emotional and behavioral disorders[31]. The SDQ
used in the NHIS includes five scales of five items each,
assessing emotional symptoms, conduct problems, hyper-
activity-inattention, peer relationship problems, and
prosocial behavior, as well as items that tap impairment
and burden[32]. The authors report estimates that
approximately 5% of the non-institutionalized U.S. pop-
ulation aged 4 – 17 experienced severe emotional difficul-
ties, with significant gender and age differences in the
estimates of problems. Notably, however, these estimates
are derived from parent reports, which for older adoles-
cents especially, may underestimate the extent of these
problems. It remains an important task, therefore, to
derive self-reported estimates of mental health problems
across the full range of adolescence.
Lucas and colleagues[33] refined the use of DISC diagnos-
tic scales for mental disorders previously employed in the
MECA study[27] by devising brief screening scales that
can be used to identify those who are likely to meet diag-
nostic criteria in full assessment. Based upon secondary
analysis of the MECA data, Lucas and colleagues applied
logistic regression models with stem items from the DISC
(i.e., questions asked of all respondents) as the independ-
ent variables and DSM-III-R diagnosis as the dependent
variable. For each specific diagnosis, the DISC predictive
scale was comprised of all the items that emerged as sig-
nificant predictors of the diagnosis in the regression[33].
Two cut-off scores were derived, one pre-defined by a pos-
itive response to any gate item (i.e., those that suggest the
need for further probing in a given area), the other con-
structed to maximize the positive prediction of the full
diagnosis based on the sum of sensitivity and specificity.
The final instrument contains 76 items, much reduced
from the 206 items in the full DISC scales[33].
For the first time in the 2000 NHSDA[34], the DISC Pre-
dictive Scale (DPS) items were included and asked of
more than 25000 adolescent respondents. This paper
reports the prevalence of symptom clusters of psychiatric
problems among adolescents in the U.S. population
derived from positive screens using the DPS. Although
such positive screens are not equivalent to diagnostic case
ascertainment – because the sensitivity and specificity
data suggest that positive screens for symptoms may be
overestimated for clinically significant disorders – these
data are important indicators of mental health problems
among age, gender and racial/ethnic subgroups that have
not been well-documented elsewhere, and such estimates
can extend our understanding of the extent of need and
inform prevention efforts[19].
Table 1: Characteristics of Adolescents Aged 12 – 17 in NHSDA and U.S. Population (Census 2000)
U.S. Population NHSDA Unweighted NHSDA Weighted
Age 12 – 17 12 – 17 12 – 17
N 24,179,360 19,430 23,367,782
Sex
Male (%) 51.4 50.7 51.2
Female (%) 48.6 49.3 48.8
Race/Ethnicity
White (%) 63.4 66.7 65.5
Black (%) 14.4 13.5 14.3
Hispanic (%) 15.2 13.9 14.2
Other (%) 7.0 5.9 6.0
Region
Northeast (%) 18.0 19.3 17.9
Midwest (%) 23.5 25.6 23.4
South (%) 35.4 32.2 35.6
West (%) 23.1 22.9 23.0
Population Density
MSA (pop≥1 m) 43.5 39.0 43.6
MSA (pop < 1 m) 35.7 34.6 33.4
Not in MSA 20.8 26.4 23.1Page 3 of 12
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Total SiPh SoPh Agor OAD OCD SAD Eat MDD Adhd ODD CD Elim Man Panic
Study based on MECAa Not in previous report b
# items in full DISC 206 14 8 4 17 13 18 7 27 44 12 24
# items in DPS 77c 7 5 3 7 7 8 3 9 13 7 9
Optimal DPS cutoff ≥ 2 ≥ 1 ≥ 1 ≥ 4 ≥ 1 ≥ 3 ≥ 2 ≥ 4 ≥ 4 ≥ 4 ≥ 2
Sensitivity 0.77 0.89 0.37 0.85 0.91 0.89 0.90 0.98 1.00 0.96 1.00
Specificity 0.79 0.74 0.96 0.92 0.72 0.85 0.88 0.90 0.85 0.94 0.98
NHSDA 2000
# items in NHSDA 71 7 2 4 4 5 7 4 7 6 7 8 3 5 2
Proposed cutoff ≥ 3 ≥ 2 ≥ 2 ≥ 3 ≥ 3 ≥ 4 ≥ 2 ≥ 5 ≥ 4 ≥ 4 ≥ 2 = 3 = 5 = 2
Note: DISC = Diagnostic Interview Schedule for Children (v2.3); DPS = DISC Predictive Scales; MECA = Methods for the Epidemiology of Child 
and Adolescent Mental Disorders; SiPh= simple phobia, a.k.a. specific anxiety in DSM-IV; SoPh = social phobia; Agor = agoraphobia; OAD = overall 
anxious disorder, or general anxiety disorder in DSM-IV; OCD = obsessive-compulsive disorders; SAD = separation anxiety disorder; Eat = eating 
disorders; MDD = major depressive disorders; ADHD = attention-deficit/hyperactivity disorder; ODD = oppositional defiant disorder; CD = 
conduct disorders; Elim = elimination disorders; Man = Mania; Panic = Panic disorders.
a. From Lucas et al. 2001. Adjustment was made based on further data analysis and pilot studies of DPS by Lucas.
b. Three sub-scales in the 2000 NHSDA were not reported in previous methodological study. Due to lack of data on sensitivity and specificity for 
these scales, we used the maximum score (positive on all items) as the cutoff for the predictive diagnosis.
c. Excluding one question on substance use disorder, which was replaced by 19 items in NHSDA.
Method
The Data
Prevalence and co-occurrence estimates of symptom clus-
ters of specific psychiatric problems were derived from the
2000 National Household Survey on Drug Abuse
(NHSDA)[34]. Specifically, we used the adolescent (12–
17 years) sample from public use file (N = 19,430), which
is a random sample of the total adolescent sample (N =
25,717)*. In the 2000 survey, a complete module of 22
items that approximates DSM-IV[36] criteria for depend-
ence and abuse on major substances such as alcohol, nic-
otine, marijuana, cocaine and other drugs was included,
making it possible to estimate the prevalence of clinically
defined dependence for each substance. Also included
was a comprehensive set of 71 mental health questions
adapted from the DPS, which provided a unique opportu-
nity to estimate the prevalence and co-occurrence of
symptom clusters of major psychiatric problems among
this critical age group in a large population sample.
The NHSDA sample is drawn using a multi-stage stratifi-
cation procedure from the civilian, non-institutionalized
U.S. population aged 12 or older. Computer-assisted face-
to-face interviews were performed in the selected house-
holds. Of the 19,340 adolescent respondents in the public
data, approximately half were female (49.3%). The racial/
ethnic composition was 67% White, 14% Black, 14% His-
panic, and 6% other race or ethnicity. Table 1 presents the
demographic characteristics of the 2000 NHSDA adoles-
cent sample and comparison data for the US population
aged 12–17 from the 2000 census[37]. Our sample devi-
ates somewhat from the comparison population only in
the distribution of adolescents in small- and non-metro-
politan areas (probably due to differing Census and
NHSDA sample frames).
The Key Variables
DISC predictive scales (DPS) were used to calculate 14
psychiatric symptom clusters. By symptom cluster we refer
to a group of symptoms derived from DSM-III-R (DISC
3.2) disorders without the criteria on impairment or dura-
tion of the symptom. To derive the score for each symp-
tom cluster, we summed across the DPS items for each
scale that were answered positively by the respondent (see
Appendix for a listing of the items used for each scale
Additional file: 1). The cutoff point for each symptom
cluster is based on previous methodological studies of
MECA[33] (see Table 2 for details). Three sub-scales in the
NHSDA – elimination, panic and mania – were not
included in the previous methodological study. Due to a
lack of data on sensitivity and specificity thresholds for
these scales, we used the maximum score (positive on all
items) to define the symptom cluster for each to minimize
over-estimation. Thus, a positive case of symptom cluster
was derived only when a respondent met the predeter-
mined cut-off for symptom items in the DISC predictive
scales. The DPS symptom clusters measured in this way
include seven anxiety problems, two affective problems;
three disruptive-behavior problems, and two miscellane-
ous problems (eating & elimination problems). Four
indexes of substance use disorders were derived using the
modules for approximate diagnosis included in the
NHSDA.
We further aggregated the DPS symptom clusters into
indexes reflecting the presence of any cluster within each
category (any anxiety, any affective, any behavior, and anyPage 4 of 12
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≥4 DPS clusters, to tap the prevalence of having any DPS
cluster and the severe co-occurrence of multiple DPS clus-
ters, respectively.
As described earlier, items included in the DPS were
derived from the full set of DISC items by logistic regres-
sion models to predict DSM diagnoses. The number of
gate items for each diagnosis-specific scale ranged from 3
to 7. Further, the cut-off points were established by "any
gate item answered positively" and by the criterion that
the "sum of sensitivity and specificity was maximized for
the positive prediction of each specific diagnosis"[33].
Sensitivity ranged from 0.37 to 1.00, with most above
0.89; specificity ranged from 0.72 to 0.98, with most
above 0.90. The subset of gate items on the final DPS
scales has been demonstrated to identify with 100% accu-
racy those respondents who don't have a diagnosis, and
further contingent items can be omitted without threat of
missing a positive case[33]. Therefore, the DPS provides
us with a useful and relatively reliable tool to identify
those in the U. S. adolescent population at elevated risk
for mental disorders.
However, it is important to keep in mind that sensitivity
and specificity information may have different implica-
tions for different base rates since they are more or less
inherent measurement properties of an instrument, but
the predictive value also depends to a great extent on the
actual probability or base rate of the measured symptom.
In other words, the information may be more relevant or
sensitive to the symptom with high prevalence in the pop-
ulation, but less relevant or informative for the symptom
with very low prevalence in the population.
Analytic Strategy
First, we estimated the prevalence for each of the 19 DPS
clusters (including the 5 SUD clusters) for the total sample
and for each subgroup, and then compared them within
demographic categories. To avoid type-I errors in the esti-
mates, we only report differences significant at the p <
0.01 level. As the NHSDA used a multiple-level sampling
procedure, the standard errors for all prevalence rates were
estimated by SUDAAN[38], a software package that uses
Taylor Series linearization techniques to adjust for sample
design effects. Next, we examined the rates of co-occur-
rence of clusters among demographic groups in two ways:
the proportion of the total sample reporting two or more
past-year DPS clusters, and the proportion of those with at
least one DPS cluster. Last, we explored and identified sig-
nificant demographic correlates of each cluster through
application of multivariate logistic regression models.
Results
Prevalence Estimates
Twelve-month prevalence of symptom clusters of psychi-
atric problem was estimated using the DPS. As shown in
Table 3, three out of five (58.1%) adolescents aged 12–17
years screened positive for at least one DPS cluster over the
12 months preceding the survey.
Gender
Although female adolescents usually report lower rates of
substance use, the prevalence of SUDs for females in this
national sample is as high as that of males. Females were
more likely to be nicotine dependent (although males
reported more nicotine use than females). Compared to
males, females reported higher rates of anxiety, affective,
and eating problems, and lower levels of the elimination
problems.
Age
Estimates of having any DPS psychiatric symptom cluster
were slightly higher for late vs. early adolescents, 59.6%
vs. 56.6%, and resulted mainly from age differences in
SUD. Late adolescents (ages 15–17) reported higher rates
of SUD and affective clusters; younger adolescents (age
12–14) report higher rates of anxiety clusters than older
adolescents (age 15–17); and no age differences emerged
in rates of behavioral clusters with the exception of
ADHD, which was more prevalent among the younger
group.
Race/Ethnicity
Blacks reported more DPS psychiatric symptom clusters
than Whites and Hispanics. As would be expected from
the literature, Blacks reported lower use of licit and illicit
substances[39], and exhibited lower estimates of SUD.
Blacks also appear to have relatively high risk for anxiety
clusters, compared to other ethnic groups. Rates of OCD
clusters among Blacks were twice as high as among
Whites, and rates for specific anxiety and agoraphobia
clusters also approached this degree of difference.
Co-Occurrence
Fifty-eight percent of the adolescent sample met risk-iden-
tification criteria for at least one psychiatric symptom
cluster in the 12 months preceding the survey. Table 4
shows that 37.7% of the sample met criteria for two or
more co-occurring symptom clusters, and 17% reported 4
or more clusters. Of those with at least one identified clus-
ter, almost two-thirds screened positive for an additional
one or more clusters: 20.9% reported two, 14.6% reported
three, and 29.4% reported four or more (i.e., severe
comorbidity). Thus, co-occurrence of mental health prob-
lems in this group appears quite high and deserving of
more attention. In general, females had higher rates of
severe comorbidity than males, with about one third ofPage 5 of 12





















































































By Sex By Race/Ethnicity By Age
Male Female White Black Hispanic 12–14 15–17
% SE b % SE % SE % SE % SE % SE % SE % SE
Anxiety Clusters
Social phobia 16.5 0.32 14.7 0.45 18.4* 0.45 15.1 0.38 22.2 0.95 17.0* 0.94 18.1 0.48 14.8* 0.39
Separation anxiety 7.3 0.22 5.5 0.28 9.1* 0.33 6.1 0.25 11.2 0.79 9.1* 0.59 9.9 0.34 4.6* 0.26
Agoraphobia 9.3 0.24 5.9 0.28 12.9* 0.39 7.5 0.25 13.7 0.75 13.0* 0.84 11.4 0.39 7.2* 0.31
Panic disorder 6.0 0.19 3.8 0.23 8.3* 0.30 5.9 0.22 7.2 0.58 5.9 0.48 6.2 0.28 5.8 0.27
General anxiety 15.0 0.29 11.4 0.38 18.9* 0.43 15.6 0.36 15.6 0.83 13.2* 0.69 14.4 0.39 15.7 0.44
Specific phobia 13.5 0.28 8.4 0.32 18.9* 0.45 11.7 0.31 20.0 0.88 14.1* 0.78 15.5 0.40 11.4* 0.38
OCD 14.4 0.30 11.8 0.40 17.1* 0.47 11.4 0.31 22.8 0.97 17.7* 0.89 15.2 0.42 13.5* 0.43
Any anxiety cluster 40.1 0.41 33.1 0.56 47.4* 0.60 36.8 0.48 50.8 1.13 42.9* 1.17 42.6 0.58 37.5* 0.60
Affective Clusters
Major depression 12.1 0.26 7.9 0.31 16.5* 0.42 12.2 0.31 10.6 0.69 12.0 0.68 10.7 0.37 13.5* 0.40
Mania 3.1 0.15 2.7 0.20 3.6* 0.21 3.2 0.19 2.8 0.35 2.7 0.31 3.0 0.21 3.3 0.21
Any affect cluster 13.4 0.28 9.2 0.34 17.9* 0.44 13.6 0.33 11.7 0.73 13.1* 0.70 12.0 0.39 14.9* 0.41
Substance Use Disorders
Alcohol abuse c 3.3 0.15 3.4 0.21 3.3 0.20 3.8 0.21 1.9 0.31 3.0* 0.35 1.2 0.13 5.4* 0.28
Alcohol dependent 1.9 0.12 1.8 0.17 1.9 0.18 2.1 0.16 0.7 0.18 1.9* 0.30 0.6 0.08 3.1* 0.24
Nicotine dependent 4.1 0.16 3.7 0.22 4.6* 0.24 5.1 0.22 1.5 0.24 3.2* 0.39 1.7 0.15 6.7* 0.30
Drug abuse c 2.0 0.13 2.1 0.18 2.0 0.17 2.1 0.15 1.7 0.31 2.6 0.43 1.0 0.12 3.1* 0.22
Drug dependent 2.4 0.13 2.6 0.20 2.2 0.16 2.5 0.17 1.7 0.28 2.3 0.38 0.9 0.11 3.8* 0.24
Any SUD 9.7 0.25 9.5 0.34 9.9 0.35 10.8 0.33 5.4 0.50 9.1* 0.68 4.0 0.22 15.5* 0.45
Disruptive-behavior Clusters
ADHD 14.7 0.29 13.8 0.41 15.6* 0.44 13.8 0.34 18.3 0.91 15.1* 0.82 16.0 0.44 13.3* 0.37
ODD 27.1 0.38 27.9 0.56 26.2 0.53 27.8 0.47 26.4 1.10 24.9 0.94 27.2 0.53 27.0 0.52
Conduct disorder 11.5 0.28 12.8 0.41 10.1* 0.39 10.9 0.32 12.4 0.79 12.2 0.73 9.3 0.34 13.6* 0.41
Any beh. cluster 36.3 0.42 37.1 0.59 35.5 0.60 36.3 0.51 38.3 1.15 34.7 1.09 36.1 0.59 36.6 0.55
Other Disorder Clusters
Eating disorder 6.1 0.19 3.7 0.23 8.7* 0.32 5.9 0.24 6.5 0.57 6.4 0.50 5.5 0.28 6.8* 0.30
Elimination 0.2 0.05 0.3 0.08 0.2 0.05 0.3 0.06 0.2 0.09 0.2 0.06 0.2 0.06 0.3 0.07
Any DPS Cluster 58.1 0.42 54.8 0.56 61.6* 0.59 56.7 0.51 62.8 1.15 58.8* 1.17 56.6 0.59 59.6* 0.58
* p < 0.01 in Chi-square test of gender, race or age differences. a DISC = Diagnostic Interview Schedule for Children, See appendix Table A; b All standard errors are estimated by SUDAAN, 
which takes multi-level sampling effects into consideration. c. Abuse only without dependence.
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ter screening positive for four or more. Black adolescents
reported higher rates of comorbid clusters than any other
ethnic group; and younger adolescents had a slightly
higher rate of comorbidity than their older counterparts.
Demographic Correlates of Psychiatric Symptom Clusters
To further understand the relationship of gender, ethnic-
ity, age and other demographic factors on the estimated
prevalence of 12-month psychiatric symptom clusters and
co-occurrence, we conducted a series of multiple logistic
regression analyses, estimated by SUDAAN, to explore the
significant demographic correlates for each domain of
clusters, for any DPS cluster, and for severe comorbidity (4
or more clusters). Table 5 presents the adjusted odds
ratios for each demographic factor in each of these LOGIT
models.
Gender
In support of the prevalence estimates reported above,
males had a lower likelihood of reporting any DPS cluster.
Specifically, they were less likely to report any anxiety or
affective cluster, or severe co-occurrence. However, males
were more likely to have a significantly elevated chance of
attention deficient and behavior problems.
Age
We analyzed the age effect on symptom clusters in three
groups, early adolescent (ages 12–13), middle-adolescent
(ages 14–15), and late adolescent (ages 16–17). Whereas
the middle adolescents were more likely to report either
any DPS symptom cluster or disruptive-behavior cluster,
there were considerable variations in the odds ratios of
reporting clusters across age groups. For example, the
younger adolescents were more likely to meet criteria for
an anxiety cluster than the older adolescents, whereas the
older adolescents were more likely to do so for an affective
cluster. Middle-adolescents had the highest risk for atten-
tion deficient and behavioral problems, suggesting the
transitory and developmental nature of these problems.
Confirming the wealth of data in the literature, the odds
of SUD increased with age: middle-adolescents were
almost four times as likely, and late adolescents eight
times as likely as early adolescents to report any SUD.
Gender-Age interactions
A number of significant gender-age interactions appeared
in the models predicting any DPS symptom cluster, anxi-
ety clusters, affective clusters, and severe co-occurrence
(see models in the lower portion of Table 5). Generally,
compared to the youngest females (12–13), middle and
late adolescent males (14–17) had lower odds for each of
these problems. Taken together with the findings of prev-
alence reported earlier, it seems that the youngest females
are at the highest risk for these clusters and for the more
severe levels of comorbidity problems.
Race/Ethnicity
Black adolescents are at greater risk than White not only
for any DPS symptom clusters but also for severe co-occur-
rence, and they are at higher risk for anxiety problems as
well. Indeed, all minority groups in this sample were more
Table 4: Co-occurrence of 12-Month Psychiatric Symptom Clusters (including SUD) among Adolescents with any DPS Symptom 
Cluster, by Gender, Age and Race/Ethnicity
No. of 12-mth clusters 0 1 2 3 4+
Among total sample (N = 19,430)
Total (%) 41.9 20.4 12.2 8.5 17.1
Male 45.2 21.5 12.4 7.9 13.0
Female 38.4 19.2 11.9 9.1 21.4
White 43.3 20.8 11.9 8.1 15.9
Black 37.2 18.7 13.5 9.1 21.4
Hispanic 41.2 20.0 12.1 8.5 18.2
Others 39.9 20.3 11.6 10.4 17.7
Age 12–14 43.4 19.3 12.0 8.2 17.1
Age 15–17 40.4 21.5 12.3 8.8 17.1
Among those with any DPS cluster (N = 11,228)
Total (%) -- 35.1 20.9 14.6 29.4
Male -- 39.2 22.6 14.4 23.8
Female -- 31.2 19.4 14.7 34.7
White -- 36.7 21.0 14.4 27.9
Black -- 29.8 21.6 14.5 34.1
Hispanic -- 34.0 20.5 14.5 31.0
Others -- 33.8 19.3 17.3 29.5
Age 12–14 -- 34.1 21.2 14.5 30.2
Age 15–17 -- 36.1 20.6 14.7 28.6Page 7 of 12
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Table 5: Odds Ratios of Demographic Correlates of 12-month Psychiatric Symptom Clusters Based on Logit Models
Correlates Any anxiety cluster Any affective cluster Any SUD Any behavior cluster Any DPS sy
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR
Sex
Male 0.55* 0.51–0.59 0.47* 0.42–0.52 0.98 0.88–1.10 1.08* 1.00–1.16 0.76*
Female 1.00 -- 1.00 -- 1.00 -- 1.00 -- 1.00
Age
12–13 1.00 -- 1.00 -- 1.00 -- 1.00 -- 1.00
14–15 0.85* 0.79–0.93 1.20* 1.07–1.35 3.96* 3.23–4.85 1.17* 1.08–1.26 1.16*
16–17 0.75* 0.68–0.81 1.34* 1.19–1.51 8.01* 6.54–9.83 1.03 0.95–1.11 1.12*
Race/ethnicity
White 1.00 -- 1.00 -- 1.00 -- 1.00 -- 1.00
Black 1.67* 1.50–1.85 0.86 0.73–1.01 0.43* 0.35–0.54 1.08 0.97–1.21 1.24*
Hispanic 1.20* 1.07–1.35 0.97 0.84–1.12 0.79* 0.64–0.98 0.97 0.87–1.09 1.06
Others 1.26* 1.06–1.49 1.24 0.98–1.56 0.79 0.57–1.09 1.09 0.91–1.30 1.14
Family income ($)
0–19,999 1.32* 1.17–1.49 0.99 0.84–1.17 1.49* 1.22–1.82 1.04 0.93–1.17 1.19*
20,000–39,999 1.33* 1.20–1.48 0.97 0.85–1.12 1.52* 1.28–1.81 1.11* 1.00–1.24 1.24*
40,000–74,999 1.04 0.94–1.15 0.96 0.83–1.10 1.21* 1.03–1.42 1.04 0.94–1.14 1.07
75,000 + 1.00 -- 1.00 -- 1.00 -- 1.00 -- 1.00
Population density
MSA 1 million+ 0.90* 0.82–0.99 0.87* 0.76–0.99 0.84* 0.72–0.99 1.05 0.95–1.15 0.96
MSA <1 million 0.98 0.90–1.08 0.95 0.84–1.07 0.92 0.79–1.06 1.05 0.96–1.15 1.02
Non-MSA 1.00 -- 1.00 -- 1.00 -- 1.00 -- 1.00
U.S. Born 0.91 0.78–1.06 0.91 0.75–1.11 1.65* 1.21–2.25 1.41* 1.19–1.67 1.09
School dropout 0.86 0.67–1.10 0.95 0.67–1.34 2.20* 1.63–2.97 1.01 0.79–1.30 1.03
Models with sex-by-age interaction ¶
Sex *Age interaction, (vs. female, age 12–13)
Male, 14–15 0.73* 0.62–0.86 0.61* 0.48–0.79 0.75 0.49–1.15 0.86 0.73–1.02 0.76*
Male, 16–17 0.67* 0.56–0.80 0.62* 0.49–0.80 0.89 0.60–1.34 0.89 0.75–1.05 0.77*
* p < .05 (two tailed test) – Models estimated by SUDAAN with correction of design effects;
¶ Shows the interactive effects only with presenting other correlates.C
l i n
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Blacks alone are at increased risk for co-occurrence once
they have met criteria for any one symptom cluster.
Family Income
Adolescents from families with lower incomes are more
likely to meet criteria for at least one psychiatric symptom
cluster and to be at risk for severe comorbidity compared
to their more affluent peers. This relationship held for
anxiety cluster and SUD, although for SUD there was
increased risk for all adolescents save those from the
wealthiest families (income ≥ $75 k).
Other Demographics
Interestingly, compared to those from non-metropolitan
areas, adolescents from the largest metropolitan areas
were at reduced risk for most psychiatric problems,
including anxiety and affective domains, SUD and co-
occurring problems. US-born adolescents had higher risk
for SUD and disruptive behavior problems in comparison
with immigrant adolescents. School dropouts were at
higher risk for SUD than those currently enrolled in
school.
Discussion
Although the data from NHSDA are not sufficient to reach
any clinical diagnosis, these unique data offer us impor-
tant descriptive information on the epidemiology of psy-
chiatric symptoms and their variations in gender and
ethnic groups among the U.S. adolescent population.
Even a conservative interpretation of these estimates from
a nationally representative sample of the U.S. adolescents
suggests that adolescent mental health problems and
related co-occurrence may be more serious than previ-
ously believed. Almost three out of five US adolescents
aged 12–17 screened positive for a symptom cluster of
specific psychiatric problem using the DPS scales in the 12
months prior to the interview. More than one third
reported a disruptive-behavior problem and a slightly
larger proportion reported an anxiety problem. Approxi-
mately one out of every eight adolescents reported an
affective problem, and one in ten had a substance use dis-
order. Although the high prevalence may be inflated by
behavioral symptoms that are likely to be significantly
reduced with maturation, these estimates should raise
serious concerns about the mental health status of U.S.
adolescents. Although these symptom clusters do not
fully emulate the diagnostic criteria of clinical disorders,
the previous study of specificity and sensitivity of DPS
suggested that these symptom clusters have good predic-
tive validity for a disorder ascertained using the DISC[33].
Parenthetically recent epidemiological reports of 12-
month DSM-IV rates of psychiatric disorders from the
World Mental Health 2000 initiative among adults in
European countries have found they are far lower than the
U.S. national rates measured with the same DSM-IV diag-
nostic protocol[40]. In the Oregon Adolescent Depression
Project, the concept of sub-threshold psychiatric condi-
tions was introduced to monitor the potential mental
health problems among adolescents[41], which is very
similar to the symptom cluster of psychiatric problem
proposed in this study. They reported that, of the 1704
adolescents in the study, 52.5% had at least one sub-
threshold disorder; of those 40% had also experienced a
comorbid sub-threshold condition, and 30% had a sec-
ond comorbid condition[41]. Based on this updated
information, our estimates of high prevalence of psychiat-
ric symptom clusters among U.S. adolescents based on the
largest national household survey are not farfetched. The
key is how we interpret these data and how we use the
information. For example, it is possible to view these as
estimates of adolescents "at-risk" rather than as ascer-
tained cases since the items used for the estimates were
derived from psychiatric symptoms used in the actual
DISC diagnostic modules. Even in instances where the
number or pattern of symptoms are sufficient for a
"screened positive" but not sufficient to constitute a recog-
nized psychological disorder, the evidence suggests that
many of these children do indeed have mental health
problems [42], and are in need of further, expert assess-
ment. We acknowledge, however, that surveys such as the
NHSDA rely upon the anonymity of their respondents to
ensure accurate collection of sensitive data; for this rea-
son, such referral is impossible.
Our results show that girls tend to have a higher rate of
mental health problems than boys, which is consistent
with the literature [15-17] and with estimates for the adult
population as reported in the NCS study[14]. However,
contradicting findings from community or treatment
samples, prevalence of disruptive-behavior problems was
similar among boys and girls; additionally, in the present
study, there were no gender differences for SUD, in con-
trast to the findings from the NCS for the US population
aged 15–24, where males had a significantly higher rate of
SUD than females. Our data also contradict previous find-
ings in this area: although numerous national surveys
consistently report lower rates of substance use among
females[17,39], we found that females were equally likely
to be dependent upon or abuse substances, suggesting the
possibility that once they begin use, females are more at
risk for developing an SUD.
Another contradictory finding emerged concerning our
estimates of disruptive behavior. In treatment samples,
males reported higher rates of disruptive-behavior prob-
lems; in our study, however, estimates of behavior prob-
lems suggest similar rates for male and female adolescents
in the general population.Page 9 of 1
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higher rate of psychiatric problems than other groups,
including anxiety problems. These findings are in marked
contrast to those reported from the NCS, where no racial
difference was found in the prevalence of anxiety disor-
ders, including simple phobia and agoraphobia[14].
However, the data for adolescents presented here are sim-
ilar to those reported from the ECA study[43].
It is interesting to notice the reduced risk of mental health
problems in large metropolitan areas, since some assume
that large metropolitan areas may have more stressors and
mental health problems, and are the areas with greater
need for mental health services. The finding here raises the
prospect that mental health service delivery to the rural
areas (e.g. mobile clinics, tele-support network, etc.)
should become a priority in health service planning.
Evidence emerging from epidemiological studies suggests
high levels of comorbid mental health problems among
children and adolescents [44-46]. The proportion of ado-
lescents in the present sample who meet criteria for more
than one psychiatric symptom cluster is astonishingly
high – about two-thirds of those with one symptom clus-
ter were at risk for other symptom clusters, and half of
these met criteria for four or more symptom clusters (see
Table 4). Such high estimates of co-occurring mental
health problems are surely deserving of attention and
raise important issues of providing appropriate treatment
and preventive interventions. We identified a number of
risk factors for severe psychiatric comorbidity including
Black race, lower family income, and being a younger
female (12–13 years old). Previous studies of the relation-
ship between psychiatric problems and substance use in
adolescents suggests an approximately linear relationship
between the intensity of use and the likelihood of having
a mental problem, especially conduct disorder [47-49].
Thus this issue remains an important topic for future stud-
ies, especially with nationally-representative samples.
Limitations
There are a number of limitations that might affect the
findings reported in this paper. First, the NHSDA is a
cross-sectional study that relies solely upon retrospective
self-reports of symptoms and behaviors; therefore, the
reliability of past 12-month recall of adolescent mental
health symptoms needs further verification.
Second, we reiterate that the DISC Predictive Scales used
to derive prevalence of psychiatric symptom clusters iden-
tify positive screens for disorders – they are not clinical
diagnoses, and should be considered as indicators of ele-
vated risk for psychiatric disorders. Compared to DSM-IV
criteria, these scales do not have the required duration or
replication measures (as DPS was developed with DISC
criteria). Even with this limitation, however, these data
speak to important patterns of age, gender and ethnic dif-
ferences in the prevalence of mental health problems
deserving of further study.
Third, the DPS does not have the impairment or severity
measures of each symptom that are frequently used in
clinical diagnoses. Estimates based on symptoms alone
can vary drastically from those derived using impairment
criteria[19]. Using these additional criteria increases the
likelihood that the ascertainment in a field interview
would more closely resemble a clinically ascertained case
in terms of severity. However, collecting this level of infor-
mation about each respondent was and is not feasible for
the type of survey used in our study. It should be noted
that using additional impairment criteria does not neces-
sarily affect caseness estimates, and the criteria we have
used for case (of at-risk) identification have shown good
sensitivity and specificity when compared to the use of a
real diagnostic interview (e.g., DISC). Moreover, children
who meet criteria for psychiatric disability without meet-
ing full DSM-IV criteria for diagnosis can be considered as
having significant psychiatric problems[42].
Finally, despite the use of anonymous and computer-
assisted interview (CAI) techniques, household surveys
tended to yield lower rates of substance use compared to
school-based surveys such as Monitoring the Future[39]
and Youth Risk Behavior Surveillance Survey[50]. Youth
matched for high-school grade and age in the NHSDA
reported lower rates of substance use than those from
other school-based surveys[51]. Therefore, although the
estimated rates of symptoms of mental health problems
in our sample of adolescents are very high, the possibility
of under-reporting in NHSDA is still of an unknown
degree and needs further studies to verify its extent.
Clinical Implications
Although the United States has a well-established system
for monitoring the pattern of drug use in the general ado-
lescent population, through both school-based sur-
veys[39] and the household survey (NHSDA), there is no
system existing for estimating rates of substance use disor-
ders and mental disorders in the population on an ongo-
ing basis and among various socio-demographic
subgroups. The current estimates of the prevalence and
co-occurrence of adolescent psychiatric problems, espe-
cially the dramatic gender and ethnic variations in differ-
ent psychiatric problem domains, may provide clinicians
with both a heightened alert and a useful tool with which
to identify potential mental health problems in the gen-
eral adolescent population, which traditionally has been
biased by extensive reliance on results from treatment
studies.Page 10 of 12
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lems more frequently than did those from other groups;
unfortunately, both Black and poorer adolescents are less
likely to receive diagnosis or treatment for mental health
problems[21,52]. Clearly, the present findings strongly
suggest a need not only for increased efforts to identify
and treat adolescents with psychiatric problems but also
to design and implement effective preventative and treat-
ment strategies for the most needy subgroups.
Integrating the DISC predictive scales in the NHSDA (now
NHSDUH) would provide an excellent mechanism for
including an expanded set of questions designed to sys-
tematically monitor and assess substance use disorders
and psychiatric problems. Perhaps by using alternating
numbers of diagnostic modules per survey iteration, NHS-
DUH can regularly include the mental health module as it
did for SUDs. Such regular inclusion of these modules will
allow for an examination of changes over time, an impor-
tant goal for estimating trends in the prevalence of mental
health problems. We recommend that the Substance
Abuse and Mental Health Service Administration study
and institute the expansion of DPS in future waves so that
researchers and policy makers can continuously monitor
the trends and patterns in adolescent mental health prob-
lems that will provide essential information for the devel-
opment of more effective prevention and intervention
programs.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
• Dr. Kevin Chen initiated the paper plan, performed data
analysis and initial literature review, and wrote up the
draft of the paper.
• Dr. Ley Killeya-Jones participated in planning of the
paper, performed most literature search and review,
wrote-up the introduction and discussion, and polished
the entire paper.
• Dr. William Vega participated in planning of the paper,
defining the concept of symptom cluster of psychiatric
problem instead of traditional "disorder", provided key
literature and conceptual support, and editing and polish-
ing the entire paper.
Note
* Due to concerns with confidentiality, we were unable to
have released to us the entire NHSDA sample by the Sub-




We would like to thank Dr. Christopher Lucas of Columbia University Col-
lege of Physicians and Surgeons for his sharing of additional pilot data on 
DISC predictive scale to help make more reasonable decisions on cutoff 
points for each symptom cluster.
References
1. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V,
Lepine JP, et al.: WHO World Mental Health Survey Consortium.
Prevalence, severity, and unmet need for treatment of mental disor-
ders in the World Health Organization World Mental Health Surveys.
JAMA 291(21):2581-90. 2004 Jun 2
2. Williams PG, Holmbeck GN, Grayson N, Greenley RN: Adolescent
health psychology.  J Clinical and Consulting Psychol 2002,
70(3):828-42.
3. Roberts RE, Attkisson CC, Rosenblatt A: Prevalence of psychopa-
thology among children and adolescents.  American Journal of
Psychiatry 1998, 155:715-725.
4. Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A: Prevalence
and development of psychiatric disorders in childhood and
adolescence.  Arch Gen Psychiatry 2003, 60:837-844.
5. Turner RJ, Gil AG: Psychiatric and substance use disorders in
South Florida: Racial/ethnic and gender contrasts in a young
adult cohort.  Arch Gen Psychiatry 2002, 59(1):43-50.
6. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE:
Lifetime prevalence and age of onset distributions of DSM-
IV disorders in the National Comorbidity Replication.  Arch
Gen Psychiatry 2005, 62:593-602.
7. Kim-Cohen J, Caspi A, Moffit TE, Harrington H, Milne BJ, Poulton R:
Prior juvenile diagnoses in adults with mental disorder:
Developmental follow-back of a prospective longitudinal
cohort.  Arch Gen Psychiatry 2003, 60(7):709-717.
8. Simon GE, Von Korff M: Recall of psychiatric history in cross-
sectional surveys: implications for epidemiological research.
Epidemiol Rev 1995, 17:221-227.
9. Giaconia RM, Reinherz HZ, Paradis AD, Hauf AM, Stashwick CK:
Major depression and drug disorders in adolescence: general
and specific impairments in early adulthood.  J Am Acad Child
Adolesc Psychiatry 2001, 40(12):1426-1433.
10. Kessler RC, Avenevoli S, Merikangas KR: Mood disorders in chil-
dren and adolescents: An epidemiologic perspective.  Biol Psy-
chiatry 2001, 49(12):1002-14.
11. Lewinsohn PM, Rohde P, Seeley JR, Klein , Gotlib IH: Psychosocial
functioning of young adults who have experienced and
recovered from Major Depressive Disorder during adoles-
cence.  J Abnormal Psychol 2003, 112(3):353-363.
12. Lewinsohn PM, Seeley JR, Hibbard J, Rohde P, Sack WH: Cross-sec-
tional and prospective relationships between physical mor-
bidity and depression in older adolescents.  J Am Acad Child
Adolesc Psychiatry 1996, 35:1120-29.
13. Woodward LJ, Fergusson DM: Life course outcomes of young
people with anxiety disorders in adolescence.  J Am Acad Child
Adolesc Psychiatry 2001, 40:1086-93.
14. Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month
prevalence of DSM-III-R psychiatric disorders in the United
States: results from the National Comorbidity Survey.  Arch
Gen Psychiatry 1994, 51:8-19.
15. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf
PJ: The epidemiology of co-occurring addictive and mental
disorders: implications for prevention and service utilization.
American Journal of Orthopsychiatry 1996, 66:17-31.
Additional File 1
"appendix_items.doc"
Click here for file
[http://www.biomedcentral.com/content/supplementary/1745-
0179-1-22-S1.doc]Page 11 of 12
(page number not for citation purposes)
Clinical Practice and Epidemiology in Mental Health 2005, 1:22 http://www.cpementalhealth.com/content/1/1/22Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
16. Robins LN, Regier DA, Editors: Psychiatric disorders in America.
In The Epidemiological Catchment Area Study New York: The Free
Press; 1991. 
17. Narrow WE, Rae DS, Robins LN, Regier DA: Revised prevalence
estimates of mental disorders in the United States: using a
clinical significance criterion to reconcile 2 surveys' esti-
mates.  Arch Gen Psychiatry 2002, 59(2):115-23.
18. Kessler RC, Chiu WT, Demler O, Walters EE: Prevalence, sever-
ity, and comorbidity of 12-month DSM-IV disorders in the
National Comorbidity Survey Replication.  Arch Gen Psychiatry
2005, 62:617-627.
19. Costello EJ, Egger H, Angold A: 10-year research update review:
The epidemiology of child and adolescent psychiatric disor-
ders: I. Methods and public health burden.  J Am Acad Child Ado-
lesc Psychiatry 2005, 44(10):972-986.
20. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC:
Twelve-month use of mental health services in the United
States.  Arch Gen Psychiatry 2005, 62:629-640.
21. Elster A, Jarosik J, VanGeest J, Fleming M: Racial and ethnic dispar-
ities in health café fro adolescents: a systematic review of the
literature.  Arch Pediatr Adolesc Med 2003, 157:867-874.
22. Ezpeleta L, Erkanli A, Costello EJ, Angold A: Epidemiology of psy-
chiatric disability in childhood and adolescence.  J Child Psychol
Psychiatr 2001, 42(7):901-914.
23. Cicchetti D, Rogosch FA: Psychopathology as risk for adoles-
cent substance use disorders: A developmental psychopa-
thology perspective.  J Clin Child Psychol 1999, 28:355-365.
24. Costello EJ, Angold A, Burns BJ, Stangl DK, Tweed DL, Erkanli A,
Worthman CM: The Great Smoky Mountains Study of Youth:
goals, designs, methods, and the prevalence of DSM-III-R dis-
orders.  Arch Gen Psychiatry 1996, 53:1129-1136.
25. Robins LN, Regier DA: Psychiatric Disorders in America.  New
York: The Free Press; 1991. 
26. Kessler RC: Sex differences in DSM-III-R psychiatric disorders
in the United States: Results from the National Comorbidity
Survey.  JAMWA 1998, 53:148-58.
27. Lahey B, Flagg EW, Bird HR, et al.: The NIMH Methods for the
Epidemiology of Child and Adolescent Mental Disorders
[MECA] Study: background and methodology.  J Am Acad Child
Adolesc Psychiatry 1996, 35:855-864.
28. Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, et al.: The
NIMH Diagnostic Interview Schedule for Children Version 2
3 [DISC-2 3]: description, acceptability, prevalence rates,
and performance in the MECA study.  J Am Acad Child Adolesc
Psychiatry 1996, 3:865-77.
29. American Psychiatry Association: Diagnostic and statistical manual of
mental disorders [3rd ed. Revised, DSM-III-R] Washington, DC: Ameri-
can Psychiatric Press; 1987. 
30. Schwab-Stone ME, Shaffer D, Dulcan MK, et al.: Criterion validity
of the NIMH Diagnostic Interview Schedule for Children,
Version 2 3 [DISC-2 3].  J Am Acad Child Adolesc Psychiatry 1996,
35:878-888.
31. Simpson GA, Bloom B, Cohen RA, Blumberg S: U.S. children with
emotional and behavioral difficulties: data from the 2001,
2002, and 2003 National Health Interview Surveys.  Advance
Data 306:. June 23 2005
32. Bourdon KH, Goodman R, Rae DS, Simpson G, Koretz DS: The
Strengths and Difficulties Questionnaire: U. S. normative
data and psychometric properties.  J Am Acad Child Adolesc Psy-
chiatry 2005, 44(6):557-564.
33. Lucas CP, Zhang H, Fisher PW, Shaffer D, Regier DA, et al.: The
DISC Predictive Scales [DPS]: Efficiently screening for diag-
noses.  J Am Acad Child Adolesc Psychiatry 2001, 40:443-9.
34. Substance Abuse and Mental Health Services Administration
[SAMHSA]: National Household Survey on Drug Abuse: Main Findings
1997 US Department of Health and Human Services, Public Health
Service; 2001. 
35. Substance Abuse and Mental Health Services Administration
[SAMHSA]: National Household Survey on Drug Abuse: Methodology
Reports and Questionnaires: 2000 Methodology Resource Book [On-line]
[http://oas.samhsa.gov/NHSDA/2kCAI/2000_CAI_Specs.pdf].
Retrieved September 24, 2005
36. American Psychiatry Association: Diagnostic and statistical manual of
mental disorders [4th ed., DSM-IV] Washington, DC: American Psychi-
atric Press; 1994. 
37. United States Bureau of the Census: United States Census, 2000, Sum-
mary File 4 [SF4] [serial on the Internet] 2003 [http://www.census.gov/
Press-Release/www/2003/SF4.html]. Accessed 2003, Dec 15
38. Shah BV, Barnwell BG, Hunt PN, LaVange LM: SUDAAN User's Manual,
Professional Software for Survey Data Analysis for Multi-stage Sample
Designs North Carolina: Research Triangle Institute; 1992. 
39. Johnston LD, O'Malley PM, Bachman JG: Monitoring The Future national
survey results on drug use, 1975–2001. Secondary school students. [NIH
publication No 02-5106] Volume 1. Bethesda[MD]: National Institute
on Drug Abues; 2002. 
40. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V,
Lepine JP, et al.: WHO World Mental Health Survey Consor-
tium. Prevalence, severity, and unmet need for treatment of
mental disorders in the World Health Organization World
Mental Health Surveys.  JAMA 2004, 291(21):2581-90.
41. Lewinsohn PM, Shankman SA, Gau JM, Klein DN: The prevalence
and comorbidity of subthreshold psychiatric conditions.  Psy-
chol Med 2004, 34(4):613-622.
42. Angold A, Costello EJ, Farmer EMZ, Burns BJ, Erkanli A: Impaired
but undiagnosed.  J Am Acad Child Adol Psychiatry 1999, 38:129-137.
43. Eaton WW, Dryman A, Weisman MM: Panic and phobia.  In Psychi-
atric disorders in America: The Epidemiological Catchment Area Study Vol-
ume 38. Edited by: Robins LN, Regier DA. New York: The Free Press;
1991:155-79. 
44. Angold A, Costello EJ, Erkalani A: Comorbidity.  J Child Psychol Psy-
chiatry 1999, 40:57-87.
45. Rohde P, Lewinsohn PM, Seeley JR: Comorbidity of unipolar
depression: II Comorbidity with other mental disorders in
adolescents and adults.  J Abnorm Psychol 1991, 100:214-222.
46. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD:
Comorbidity of substance use disorders with mood and anx-
iety disorders: results of the international consortium in psy-
chiatric epidemiology.  Addictive Behaviors 1998, 23:893-907.
47. Biederman J, Wilens T, Mick E, Faraone SV, Weber W, Curtis S, et al.:
Is ADHD a risk factor or psychoactive substance use disor-
ders? Findings from a four-year prospective follow up study.
J Am Acad Child Adolesc Psychiatry 1997, 36(1):21-29.
48. Brook J, Whiteman M, Nomura C, Gordon AS: Personality, family,
and ecological influences on adolescents drug use: A devel-
opmental analysis.  Journal of Chemical Dependency Treatment 1998,
1(2):123-161.
49. Kandel DB, Johnson JG, Bird HR: Psychiatric comorbidity among
adolescents with substance use disorders: Findings from the
MECA Study.  J Am Acad Child Adolesc Psychiatry 1999, 38(6):693-99.
50. Center for Disease Control and Prevention: Youth Risk Behavior Sur-
veillance System: Assessing the Health Risk Behaviors of Young People
Atlanta [GA]: Centers for Disease Control and Prevention; 2001. 
51. Fendrich M, Johnson TP: Examining prevalence differences in
three national surveys of youth: Impact of consent proce-
dures, mode, and editing rules.  Journal of Drug Issues 2001,
31(3):615-42.
52. National Institute on Drug Abuse: Drug use among racial/ethnic minori-
ties [revised] [DHHS Pub No NIH 03-3888] Rockville, MD: National
Institute on Drug Abuse; 2003. Page 12 of 12
(page number not for citation purposes)
